{"title":"The unglamourous AI wins that are quietly transforming drug discovery and development","authors":"Asher Mullard","doi":"10.1038/d41573-026-00099-1","DOIUrl":"10.1038/d41573-026-00099-1","url":null,"abstract":"David Reese, Amgen’s inaugural Chief Technology Officer, discusses how inconspicuous AI achievements stand to transform drug discovery. David Reese, Amgen’s inaugural Chief Technology Officer, discusses how inconspicuous AI achievements stand to transform drug discovery.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"25 7","pages":"507-508"},"PeriodicalIF":91.2,"publicationDate":"2026-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/d41573-026-00099-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148239686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}